Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Zoetis Inc. (ZTS) Guidance & Earnings Results

On 2026-08-06 Zoetis Inc. lowered guidance: "FY2026 revenue guidance cut to $9.12-9.32B from prior; adjusted EPS guidance cut to…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ZTSZoetis Inc.Follow ZTS — free
Drug Manufacturers - Specialty & Generic · Healthcare
—
Price chart with a free account
Market cap
33.5B
P/E TTM
13.3
Dividend yield
2.5%
52-week
—
Next earnings
5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
6 Aug 26LoweredFY2026 revenue guidance cut to $9.12-9.32B from prior; adjusted EPS guidance cut to $6.15-6.25 · full year
7 May 26LoweredFY26 revenue $9.680-9.960B (organic growth 2-5%); adjusted net income $2.870-2.950B (organic growth 2-6%); adjusted diluted EPS $6.85-7.00 · full year
12 Feb 26ReaffirmedFY 2026 revenue $9.825-$10.025B, organic growth 3-5%. · full year
4 Nov 25ReaffirmedFY25 revenue $9.400-9.475B, adjusted EPS $6.30-6.40 · full year
5 Aug 25RaisedFY25 revenue $9.45-9.6B; FY25 organic operational revenue growth 6.5-8.0%; FY25 organic operational adjusted net income growth 5.5-7.5%; FY25 adjusted diluted EPS $6.30-6.40 · full year

Zoetis Inc. — questions

What guidance did Zoetis Inc. give?
On 2026-08-06: "FY2026 revenue guidance cut to $9.12-9.32B from prior; adjusted EPS guidance cut to $6.15-6.25"
When does Zoetis Inc. report earnings?
Zoetis Inc.'s next earnings report is expected on 2026-11-05.

Every figure on this page comes from Zoetis Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.